Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 2.1 trillion as of November 5, 2025. Its market cap has increased by 6.94% in one year.

Market Cap

2.10T

Enterprise Value

2.09T

Revenue

150.09B

Ranking

n/a

PE Ratio

939.74

Stock Price

39,150.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.10T, an increase of 7,880.11%. That is a compound annual growth rate of 15.60%.

Market Cap History

Date	Market Cap	% Change
Nov 4, 2025	2.10T	7.08%
Dec 30, 2024	1.96T	-12.72%
Dec 28, 2023	2.25T	148.89%
Dec 29, 2022	902.29B	-16.29%
Dec 30, 2021	1.08T	-43.84%
Dec 30, 2020	1.92T	3.31%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	86.90T
Celltrion	38.84T
ALTEOGEN	29.36T
SK Biopharmaceuticals	9.42T
Yuhan	9.01T
HLB Co., Ltd.	7.03T
ABL Bio	6.13T
Peptron	6.11T

Market Cap Rankings